Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519779 · ClinicalTrials.gov registry record · Phase 2
Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
NCT00519779: Completed Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00519779 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 68 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00519779, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
Study Summary
This study is designed to examine the effects of fish oil on immune function and mood in medical students.
Primary Outcome
log-transformed serum Interleukin-6 (IL-6) Serum cytokine levels provide an assessment of systemic inflammation, the cytokine level circulating throughout the body. Higher levels are typically interrupted as worse unless an individual is acutely ill. Stimulated cytokine production reflects the inflammatory cytokine production capacity of monocytes.
Interventions
- DIETARY_SUPPLEMENT omega-3 supplementation
- DIETARY_SUPPLEMENT Oral omega-3 fish oil placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
What the finished NCT00519779 record still lists
NCT00519779 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (49% lower).
The record links to 0 conditions, and to 2 interventions - of which omega-3 supplementation is the first listed.
NCT00519779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00519779 about?
NCT00519779 is a clinical study titled "Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention". This study is designed to examine the effects of fish oil on immune function and mood in medical students.
What is the current status of trial NCT00519779?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 2007-07. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00519779?
The interventions under investigation include: omega-3 supplementation (DIETARY_SUPPLEMENT), Oral omega-3 fish oil placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00519779?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00519779's enrollment target sits among peer trials
68 967th of 2000 higher than 1,027 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia